Quinuclidine derivatives binding to mucarinic M3 receptors

Details for Australian Patent Application No. 2004234069 (hide)

Owner Novartis AG

Inventors Bhalay, Gurdip; Cox, Brian; Collingwood, Stephen Paul; Baettig, Urs; Devereux, Nicholas James

Agent Davies Collison Cave

Pub. Number AU-B-2004234069

PCT Pub. Number WO2004/096800

Priority 0310232.4 02.05.03 GB; 0324887.9 24.10.03 GB

Filing date 30 April 2004

Wipo publication date 11 November 2004

Acceptance publication date 21 February 2008

International Classifications

C07D 453/02 (2006.01) Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

C07D 519/00 (2006.01) Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or

Event Publications

10 November 2005 PCT application entered the National Phase

  PCT publication WO2004/096800 Priority application(s): WO2004/096800

21 February 2008 Application Accepted

  Published as AU-B-2004234069

19 June 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004234071-Synthesis of solanum glycosides

2004234068-Inhibitors of phosphatidylinositol 3-kinase